Kenneth Greathouse is Director at Zosano Pharma Corp (ZSAN). They have made 4 open-market trades across 1 company since 2017, most recently 2021-11-23.
CIK 0001191287
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
3 open-market purchases totalling $124K since 2017, against 1 sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| ZSAN | 43,500 | $24K |
Shares reported on the most recent Form 4, priced at the 2021-11-24 close.
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.